Zydus Lifesciences informs about press release

27 Nov 2025 Evaluate

Zydus Lifesciences has informed that it enclosed press release titled ‘Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg.’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

884.80 8.70 (0.99%)
22-Jan-2026 13:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.80
Dr. Reddys Lab 1222.15
Cipla 1375.80
Zydus Lifesciences 884.80
Lupin 2171.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×